首页> 美国卫生研究院文献>Molecules >Enzyme Stability in Nanoparticle Preparations Part 1: Bovine Serum Albumin Improves Enzyme Function
【2h】

Enzyme Stability in Nanoparticle Preparations Part 1: Bovine Serum Albumin Improves Enzyme Function

机译:纳米粒子制剂中的酶稳定性第1部分:牛血清白蛋白改善酶功能

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Enzymes have gained attention for their role in numerous disease states, calling for research for their efficient delivery. Loading enzymes into polymeric nanoparticles to improve biodistribution, stability, and targeting in vivo has led the field with promising results, but these enzymes still suffer from a degradation effect during the formulation process that leads to lower kinetics and specific activity leading to a loss of therapeutic potential. Stabilizers, such as bovine serum albumin (BSA), can be beneficial, but the knowledge and understanding of their interaction with enzymes are not fully elucidated. To this end, the interaction of BSA with a model enzyme B-Glu, part of the hydrolase class and linked to Gaucher disease, was analyzed. To quantify the natural interaction of beta-glucosidase (B-Glu,) and BSA in solution, isothermal titration calorimetry (ITC) analysis was performed. Afterwards, polymeric nanoparticles encapsulating these complexes were fully characterized, and the encapsulation efficiency, activity of the encapsulated enzyme, and release kinetics of the enzyme were compared. ITC results showed that a natural binding of 1:1 was seen between B-Glu and BSA. Complex concentrations did not affect nanoparticle characteristics which maintained a size between 250 and 350 nm, but increased loading capacity (from 6% to 30%), enzyme activity, and extended-release kinetics (from less than one day to six days) were observed for particles containing higher B-Glu:BSA ratios. These results highlight the importance of understanding enzyme:stabilizer interactions in various nanoparticle systems to improve not only enzyme activity but also biodistribution and release kinetics for improved therapeutic effects. These results will be critical to fully characterize and compare the effect of stabilizers, such as BSA with other, more relevant therapeutic enzymes for central nervous system (CNS) disease treatments.
机译:酶在许多疾病状态下都会有所关注,呼吁研究其有效的交付。将酶加载到聚合物纳米粒子中以改善生物分布,稳定性和靶向体内的靶向导致该领域具有有前途的结果,但这些酶仍然患有在制剂过程中的降解效果,导致降低动力学和特异性活性,导致治疗的丧失丧失潜在的。稳定剂,例如牛血清白蛋白(BSA),可以是有益的,但对其与酶的相互作用的知识和理解没有完全阐明。为此,分析了BSA与模型酶B-Glu的相互作用,水解酶的一部分和与Gaucher病联系起来。为了量化β-葡糖苷酶(B-Glu,)和BSA在溶液中的自然相互作用,进行等温滴定热量法(ITC)分析。然后,将包封这些配合物的聚合物纳米颗粒完全表征,并进行了包封效率,包封酶的活性,并进行了酶的释放动力学。 ITC结果表明,B-Glu和BSA之间看到了1:1的自然结合。复合浓度不影响纳米粒子特性,其保持在250至350nm之间的尺寸,但增加了载荷能力(从6%至30%),酶活性和延长释放动力学(从不到一天到六天)对于含有较高B-Glu的颗粒:BSA比率。这些结果突出了了解酶的重要性:各种纳米颗粒系统中的稳定剂相互作用,不仅改善酶活性,还改善生物分布和释放动力学,以改善治疗效果。这些结果对于充分表征和比较稳定剂的影响,例如BSA与其他更相关的中枢神经系统(CNS)疾病治疗的疾病治疗的影响至关重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号